Duliege Anne-Marie
EVP & Chief Medical Officer at RIGL; EVP, Chief of Strategic Dev. at ChemoCentryx, Inc.; Chief Medical Officer at AFFYMAX INC
- Sold, on record
- $3M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Sep 17, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- RIGLRIGEL PHARMACEUTICALS INCEVP & Chief Medical Officer
- ChemoCentryx, Inc.EVP, Chief of Strategic Dev.
- AFFYMAX INCChief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- RIGL189,500 shares
- AFFYMAX INC111,060 shares
- ChemoCentryx, Inc.4,970 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale AFFYMAX INCPlan not statedNov 1, 2012 2012
Sold 1,056 shares at $22.90 ($24k)
Duliege Anne-Marie, Chief Medical Officer
Sold 4.4% of holdings ($554k position)23,125 shares left0.2x usual sizeFiling
- 2 Form 4 sale ChemoCentryx, Inc.UnusualNov 18, 2014 +747 days
Sold 4,970 shares at $4.71 ($23k)
Duliege Anne-Marie, EVP, Chief of Strategic Dev.
Sold 100% of holdings ($23k position)0 shares leftFirst sale on recordFiling
- 3 Form 4 sale RIGLUnusualJan 3, 2017 +777 days
Sold 5,000 shares at $2.41 ($12k)
Duliege Anne-Marie, Chief Medical Officer
Sold 100% of holdings ($12k position)0 shares leftFirst sale on recordFiling
- 4 Form 4 sale RIGLUnusualJul 5, 2017 +183 days
Sold 5,000 shares at $2.69 ($13k)
Duliege Anne-Marie, Chief Medical Officer
Sold 100% of holdings ($13k position)0 shares leftFiling
- 5 Form 4 sale RIGLUnusualApr 20, 2018 +289 days
Sold 5,000 shares at $4.11 ($21k)
Duliege Anne-Marie, EVP & Chief Medical Officer
Sold 100% of holdings ($21k position)0 shares leftFiling
- 6 Form 4 sale RIGLUnusualJul 2, 2018 +73 days
Sold 5,000 shares at $2.79 ($14k)
Duliege Anne-Marie, EVP & Chief Medical Officer
Sold 100% of holdings ($14k position)0 shares left1x usual sizeFiling
- 7 Form 4 sale RIGLUnusualSep 4, 2018 +64 days
Sold 16,500 shares at $3.51 ($58k)
Duliege Anne-Marie, EVP & Chief Medical Officer
Sold 100% of holdings ($58k position)0 shares left3.3x usual sizeFiling
- 8 Form 4 sale RIGLUnusualSep 17, 2018 +13 days
Sold 153,000 shares at $3.50 ($536k)
Duliege Anne-Marie, EVP & Chief Medical Officer
Sold 100% of holdings ($536k position)0 shares left30.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2018 | Sep 19, 2018 | RIGL | EVP & Chief Medical Officer | Form 4 sale | 153,000 | $536k | 100.0% | Unusual | SEC |
| Sep 4, 2018 | Sep 6, 2018 | RIGL | EVP & Chief Medical Officer | Form 4 sale | 16,500 | $58k | 100.0% | Unusual | SEC |
| Jul 2, 2018 | Jul 5, 2018 | RIGL | EVP & Chief Medical Officer | Form 4 sale | 5,000 | $14k | 100.0% | Unusual | SEC |
| Apr 20, 2018 | Apr 24, 2018 | RIGL | EVP & Chief Medical Officer | Form 4 sale | 5,000 | $21k | 100.0% | Unusual | SEC |
| Jul 5, 2017 | Jul 7, 2017 | RIGL | Chief Medical Officer | Form 4 sale | 5,000 | $13k | 100.0% | Unusual | SEC |
| Jan 3, 2017 | Jan 13, 2017 | RIGL | Chief Medical Officer | Form 4 sale | 5,000 | $12k | 100.0% | Unusual | SEC |
| Nov 18, 2014 | Nov 20, 2014 | ChemoCentryx, Inc. | EVP, Chief of Strategic Dev. | Form 4 sale | 4,970 | $23k | 100.0% | Unusual | SEC |
| Nov 1, 2012 | Nov 5, 2012 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 1,056 | $24k | 4.4% | Plan not stated | SEC |
| Oct 10, 2012 | Oct 12, 2012 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 9,704 | $233k | 29.6% | Unusual | SEC |
| Sep 13, 2012 | Sep 17, 2012 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 23,227 | $465k | 41.4% | Unusual | SEC |
| May 25, 2012 | May 30, 2012 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 3,689 | $52k | 10.1% | Plan not stated | SEC |
| Nov 1, 2011 | Nov 3, 2011 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 823 | $4k | 3.2% | Plan not stated | SEC |
| Aug 17, 2011 | Aug 18, 2011 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 5,296 | $25k | 17.7% | Plan not stated | SEC |
| May 4, 2010 | May 5, 2010 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 4,197 | $101k | 100.0% | Unusual | SEC |
| Mar 16, 2010 | Mar 17, 2010 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 24,083 | $503k | 100.0% | Unusual | SEC |
| Nov 10, 2009 | Nov 12, 2009 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 3,000 | $61k | 100.0% | Unusual | SEC |
| Sep 3, 2009 | Sep 3, 2009 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 3,250 | $72k | 100.0% | Unusual | SEC |
| Sep 1, 2009 | Sep 2, 2009 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 30,000 | $722k | 100.0% | Unusual | SEC |
| May 1, 2009 | May 1, 2009 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 1,697 | $30k | 100.0% | Unusual | SEC |
| May 15, 2008 | May 16, 2008 | AFFYMAX INC | Chief Medical Officer | Form 4 sale | 1,038 | $16k | 100.0% | Unusual | SEC |